Inflammation in venous thromboembolism: Cause or consequence?

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 655-665

  Saghazadeh, Amene ^a   Hafizi, Sina ^a   Rezaei, Nima ^a,b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSAL SCIENTIFIC EDUCATION AND RESEARCH NETWORK USERN   (Iran)

Author keywords

Cytokines; Deep vein thrombosis; Inflammation; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; GROWTH ARREST SPECIFIC PROTEIN 6; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN S; THROMBOPLASTIN; IMMUNOLOGIC FACTOR;

AIR POLLUTION; ARTICLE; CYTOKINE PRODUCTION; EMBOLISM PREVENTION; EVIDENCE BASED PRACTICE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE; LUNG EMBOLISM; LYMPHOCYTE; MACROPHAGE; MEDIATOR RELEASE; MEMBRANE MICROPARTICLE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SIGNAL TRANSDUCTION; VENOUS THROMBOEMBOLISM; ANIMAL; COMPLICATION; IMMUNOLOGY; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; CYTOKINES; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84939508119     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.07.044     Document Type: Review

References (127)

1. P. Prandoni, A.W.A. Lensing, A. Cogo, S. Cuppini, S. Villalta, M. Carta, and et al. The long-term clinical course of acute deep venous thrombosis Ann. Intern. Med. 125 1996 1 7
2. C. Huerta, S. Johansson, M.-A. Wallander, and L.A.G. Rodríguez Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom Arch. Intern. Med. 167 2007 935 943
3. H. Shbaklo, C.A. Holcroft, and S.R. Kahn Levels of inflammatory markers and the development of the post-thrombotic syndrome Thromb. Haemost. 101 2009 505 512
4. F.A. Anderson, and F.A. Spencer Risk factors for venous thromboembolism Circulation 107 2003 I-9
5. A.R. Folsom, L.L. Boland, M. Cushman, S.R. Heckbert, W.D. Rosamond, and J.D. Walston Frailty and risk of venous thromboembolism in older adults J. Gerontol. A: Biol. Med. Sci. 62 2007 79 82
6. E. Daly, M.P. Vessey, M.M. Hawkins, J.L. Carson, P. Gough, and S. Marsh Risk of venous thromboembolism in users of hormone replacement therapy Lancet 348 1996 977 980
7. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, M.R. Lassen, and et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines Chest J. 133 2008 381S 453S
8. G.H. Lyman, A.A. Khorana, A. Falanga, D. Clarke-Pearson, C. Flowers, M. Jahanzeb, and et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J. Clin. Oncol. 25 2007 5490 5505
9. S.M. Bates, I.A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines CHEST J. 133 2008 844S 886S
10. O. Baser, X. Liu, H. Phatak, L. Wang, J. Mardekian, H. Kawabata, and et al. Venous thromboembolism prophylaxis and clinical consequences in medically ill patients Am. J. Ther. 20 2013 132 142
11. J.M. Stinnett, R. Pendleton, L. Skordos, M. Wheeler, and G.M. Rodgers Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates Am. J. Hematol. 78 2005 167 172
12. P.A. Kyrle, and S. Eichinger Deep vein thrombosis Lancet 365 2005 1163 1174
13. B. Furie, and B.C. Furie Mechanisms of thrombus formation N. Engl. J. Med. 359 2008 938 949
14. P.S. Wells, D.R. Anderson, M. Rodger, M. Forgie, C. Kearon, J. Dreyer, and et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis N. Engl. J. Med. 349 2003 1227 1235
15. T.W. Wakefield, D.D. Myers, and P.K. Henke Mechanisms of venous thrombosis and resolution Arterioscler. Thromb. Vasc. Biol. 28 2008 387 391
16. M.H. Meissner, T.W. Wakefield, E. Ascher, J.A. Caprini, A.J. Comerota, B. Eklof, and et al. Acute venous disease: venous thrombosis and venous trauma J. Vasc. Surg. 46 Suppl. S 2007 25S 53S
17. C. Kroegel, and A. Reissig Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis Respiration 70 2003 7 30
18. K.B. Cheng, L.M. Wang, H.J. Gao, and Y. Hu An study on screening the gene clusters associated with pulmonary embolism-deep venous thrombosis by oligo microarray Zhonghua Yi Xue Za Zhi 87 2007 2420 2422
19. J. Bernard, and E.S. Yi Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution Hum. Pathol. 38 2007 871 877
20. K.C. Zapponi, B.M. Mazetto, L.F. Bittar, A. Barnabe, F.D. Santiago-Bassora, E.V. De Paula, and et al. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels Thromb. Res. 133 2014 736 742
21. B.M. Mazetto, F.L. Orsi, A. Barnabe, E.V. De Paula, M.C. Flores-Nascimento, and J.M. Annichino-Bizzacchi Increased ADAMTS13 activity in patients with venous thromboembolism Thromb. Res. 130 2012 889 893
22. M.F. Matos, D.M. Lourenco, C.M. Orikaza, J.A. Bajerl, M.A. Noguti, and V.M. Morelli The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 - 174GC, IL-8 - 251AT and MCP-1 - 2518AG in the risk of venous thromboembolism: a case-control study Thromb. Res. 128 2011 216 220
23. T.W. Wakefield, L.J. Greenfield, M.W. Rolfe, A. DeLucia 3rd, R.M. Strieter, G.D. Abrams, and et al. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis Thromb. Haemost. 69 1993 164 172
24. B. Halici, S. Sarinc Ulasli, E. Gunay, S. Nural, S. Sen, O. Akar, and et al. Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: follow-up results Inflammation 37 2014 1186 1190
25. A. Montes-Worboys, E. Arellano, T. Elias, J. Leon, J.A. Rodriguez-Portal, and R. Otero Residual thrombosis after a first episode of proximal deep venous thrombosis Blood Coagul. Fibrinolysis 24 2013 335 360
26. B.A. Steppich, M. Hassenpflug, S.L. Braun, K. Schomig, O. von Beckerath, N. von Beckerath, and et al. Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis VASA Z. Gefasskrankheiten 40 2011 117 122
27. G. Grignani, and A. Maiolo Cytokines and hemostasis Haematologica 85 2000 967 972
28. M.F. Matos, D.M. Lourenco, C.M. Orikaza, C.P. Gouveia, and V.M. Morelli Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6 Metab. Syndr. Relat. Disord. 11 2013 29 34
29. M.K. Jezovnik, and P. Poredos Factors influencing the recanalisation rate of deep venous thrombosis Int. Angiol. 31 2012 169 175
30. P.J. Marchena Yglesias, J.A. Nieto Rodriguez, S. Serrano Martinez, O. Belinchon Moya, A. Cortes Carmona, A. Diaz de Tuesta, and et al. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters An. Med. Espec. 23 2006 105 110
31. P. Maruna, J. Kunstyr, K.M. Plocova, F. Mlejnsky, J. Hubacek, A.A. Klein, and et al. Predictors of infection after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension Eur. J. Cardiothorac. Surg. 39 2011 195 200
32. R. Vormittag, K. Hsieh, A. Kaider, E. Minar, C. Bialonczyk, M. Hirschl, and et al. Interleukin-6 and interleukin-6 promoter polymorphism (- 174) G>C in patients with spontaneous venous thromboembolism Thromb. Haemost. 95 2006 802 806
33. B.M. Wojcik, S.K. Wrobleski, A.E. Hawley, T.W. Wakefield, D.D. Myers Jr., and J.A. Diaz Interleukin-6: a potential target for post-thrombotic syndrome Ann. Vasc. Surg. 25 2011 229 239
34. A.C. Bouman, Y.W. Cheung, H.M. Spronk, C.G. Schalkwijk, H. Ten Cate, M. Ten Wolde, and et al. Biomarkers for post thrombotic syndrome: a case-control study Thromb. Res. 134 2014 369 375
35. B. Battistini Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism Can. J. Physiol. Pharmacol. 81 2003 555 569
36. L. Han, Q.Y. Li, L. Zhou, X. Wang, Z.Y. Bao, M. Li, and et al. Effects of thrombolytic drugs and a selective endothelin-1 receptor antagonist on acute pulmonary thromboembolism in dogs Chin. Med. J. 123 2010 395 400
37. J. Tsang, M. Simon, K. Stewart, K. Qayumi, and B. Battistini Proinflammatory cytokines are not released in the circulation following acute pulmonary thromboembolism in pigs J. Invest. Surg. 15 2002 29 35
38. M.J. Eagleton, P.K. Henke, C.E. Luke, A.E. Hawley, A. Bedi, B.S. Knipp, and et al. Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism J. Vasc. Surg. 36 2002 581 588
39. H. Kimura, O. Okada, N. Tanabe, Y. Tanaka, M. Terai, Y. Takiguchi, and et al. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension Am. J. Respir. Crit. Care Med. 164 2001 319 324
40. J. Zagorski, J. Debelak, M. Gellar, J.A. Watts, and J.A. Kline Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres J. Immunol. 171 2003 5529 5536
41. J.A. Watts, J. Zagorski, M.A. Gellar, B.G. Stevinson, and J.A. Kline Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats J. Mol. Cell. Cardiol. 41 2006 296 307
42. G.J. Stewart Neutrophils and deep venous thrombosis Haemostasis 23 Suppl. 1 1993 127 140
43. E. Krieger, B. van Der Loo, B.R. Amann-Vesti, V. Rousson, and R. Koppensteiner C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis J. Vasc. Surg. 40 2004 644 649
44. M.R. Varma, A.J. Varga, B.S. Knipp, P. Sukheepod, G.R. Upchurch, S.L. Kunkel, and et al. Neutropenia impairs venous thrombosis resolution in the rat J. Vasc. Surg. 38 2003 1090 1098
45. F.F. Liu, Z.G. Zhai, Y.H. Yang, J. Wang, and C. Wang Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism Zhonghua Yi Xue Za Zhi 93 2013 1860 1863
46. G. Nakos, E.I. Kitsiouli, and M.E. Lekka Bronchoalveolar lavage alterations in pulmonary embolism Am. J. Respir. Crit. Care Med. 158 1998 1504 1510
47. M.M. Orde, R. Puranik, P.L. Morrow, and J. Duflou Myocardial pathology in pulmonary thromboembolism Heart 97 2011 1695 1699
48. E.M. Bakirci, S. Topcu, K. Kalkan, I.H. Tanboga, A. Borekci, S. Sevimli, and et al. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism Clin. Appl. Thromb. Hemost. 2013 10.1177/1076029613494469
49. J.A. Watts, M.A. Gellar, M. Obraztsova, J.A. Kline, and J. Zagorski Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats Int. J. Exp. Pathol. 89 2008 389 399
50. L.J. Downing, R.M. Strieter, A.M. Kadell, C.A. Wilke, S.L. Brown, S.K. Wrobleski, and et al. Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation ASAIO J. 42 1996 M677 M682
51. M. Zolcinski, M. Ciesla-Dul, D.P. Potaczek, and A. Undas Atorvastatin favorably modulates proinflammatory cytokine profile in patients following deep vein thrombosis Thromb. Res. 132 2013 e31 e35
52. K.E. Nordenholz, A.M. Mitchell, and J.A. Kline Direct comparison of the diagnostic accuracy of fifty protein biological markers of pulmonary embolism for use in the emergency department Acad. Emerg. Med. 15 2008 795 799
53. P.D. Stein, R.D. Hull, K.C. Patel, R.E. Olson, W.A. Ghali, R. Brant, and et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review Ann. Intern. Med. 140 2004 589 602
54. J.J. Sidelmann, F. Vitzthum, E. Funding, A.M. Munster, J. Gram, and J. Jespersen Factor VII-activating protease in patients with acute deep venous thrombosis Thromb. Res. 122 2008 848 853
55. A.C. Bouman, J.J. Smits, H. Ten Cate, and A.J. Ten Cate-Hoek Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome J. Thromb. Haemost. 10 2012 1532 1538
56. J. Zacho, A. Tybjaerg-Hansen, and B.G. Nordestgaard C-reactive protein and risk of venous thromboembolism in the general population Arterioscler. Thromb. Vasc. Biol. 30 2010 1672 1678
57. M. Feldman, B. Aziz, G.N. Kang, M.A. Opondo, R.K. Belz, and C. Sellers C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults Transl. Res. 161 2013 37 43
58. S.V. Sveinsdottir, P.J. Svensson, and G. Engstrom Inflammatory plasma markers and risk for venous thromboembolism J. Thromb. Thrombolysis 38 2014 190 195
59. A.W. Tsai, M. Cushman, W.D. Rosamond, S.R. Heckbert, R.P. Tracy, N. Aleksic, and et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE) Am. J. Med. 113 2002 636 642
60. B. Luxembourg, J. Schmitt, M. Humpich, M. Glowatzki, D. Dressler, E. Seifried, and et al. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: a focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP) Thromb. Haemost. 102 2009 668 675
61. P. Taura, E. Rivas, G. Martinez-Palli, A. Blasi, J.C. Holguera, J. Balust, and et al. Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery Surg. Endosc. 28 2014 543 551
62. T. Gary, K. Belaj, R. Bruckenberger, G. Hackl, F. Hafner, H. Froehlich, and et al. Primary antiphospholipid antibody syndrome - one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism Obesity (Silver Spring) 21 2013 E463 E466
63. J.A. Chirinos, G.A. Heresi, H. Velasquez, W. Jy, J.J. Jimenez, E. Ahn, and et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism J. Am. Coll. Cardiol. 45 2005 1467 1471
64. A.J. Gonzalez-Ordonez, J.M. Fernandez-Carreira, C.R. Fernandez-Alvarez, R. Venta Obaya, M.D. Macias-Robles, A. Gonzalez-Franco, and et al. The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism Haematologica 88 2003 1035 1043
65. T. Chung, D. Connor, J. Joseph, L. Emmett, R. Mansberg, M. Peters, and et al. Platelet activation in acute pulmonary embolism J. Thromb. Haemost. 5 2007 918 924
66. D.D. Myers Jr., J.E. Rectenwald, P.W. Bedard, N. Kaila, G.D. Shaw, R.G. Schaub, and et al. Decreased venous thrombosis with an oral inhibitor of P selectin J. Vasc. Surg. 42 2005 329 336
67. T.W. Wakefield, R.M. Strieter, R. Schaub, D.D. Myers, M.R. Prince, S.K. Wrobleski, and et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy J. Vasc. Surg. 31 2000 309 324
68. J.E. Slotta, O.O. Braun, M.D. Menger, and H. Thorlacius Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162 Platelets 20 2009 505 512
69. M.R. Rossiello, S. Momi, R. Caracchini, S. Giannini, G. Guglielmini, A. Monopoli, and et al. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression J. Thromb. Haemost. 3 2005 2554 2562
70. J.J. Sidelmann, E.M. Bladbjerg, J. Gram, A.M. Munster, and J. Jespersen Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis Blood Coagul. Fibrinolysis 19 2008 405 409
71. M.D. Blostein, I. Rajotte, D.P. Rao, C.A. Holcroft, and S.R. Kahn Elevated plasma gas6 levels are associated with venous thromboembolic disease J. Thromb. Thrombolysis 32 2011 272 278
72. D. Borgel, S. Clauser, C. Bornstain, I. Bièche, A. Bissery, V. Remones, and et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis Crit. Care Med. 34 2006 219 222
73. S. Dahi, J.G. Lee, D.H. Lovett, and R. Sarkar Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin J. Vasc. Surg. 42 2005 539 545
74. J. Zhang, L. Xia, X. Zhang, W. Yang, and M. Bai Influence of l-arginine on the expression of eNOS and COX2 in experimental pulmonary thromboembolism J. Huazhong Univ. Sci. Technolog. Med. Sci. 26 2006 524 527
75. L. Wang, J. Wu, W. Zhang, Y. Zhi, Y. Wu, R. Jiang, and et al. Effects of aspirin on the ERK and PI3K/Akt signaling pathways in rats with acute pulmonary embolism Mol. Med. Rep. 8 2013 1465 1471
76. Y. Ueno, H. Koike, S. Annoh, and S. Nishio Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms Prostaglandins 53 1997 279 289
77. J.B. Smith, and A.L. Willis Aspirin selectively inhibits prostaglandin production in human platelets Nature 231 1971 235 237
78. M. Martinez, A. Cuker, A. Mills, R. Lightfoot, Y. Fan, W.H. Tang, and et al. Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism Free Radic. Biol. Med. 53 2012 230 236
79. Y.K. Chae, D. Khemasuwan, A. Dimou, S. Neagu, L. Chebrolu, S. Gupta, and et al. Inhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease PLoS One 9 2014 e87813
80. A.R. Brasier, A. Recinos, and M.S. Eledrisi Vascular inflammation and the renin-angiotensin system Arterioscler. Thromb. Vasc. Biol. 22 2002 1257 1266
81. V.J. Dzau Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis Hypertension 37 2001 1047 1052
82. D.X. Zhang, L. Zhang, and M. Bai The expression levels of endothelin-1 and nuclear factor-kappaB in the lung tissue of acute pulmonary embolism and the effects of thrombolysis and dexamethasone Zhonghua Jie He He Hu Xi Za Zhi 28 2005 604 607
83. C.M. Stutz, L.D. O'Rear, K.R. O'Neill, M.E. Tamborski, C.G. Crosby, C.J. Devin, and et al. Coagulopathies in orthopaedics: links to inflammation and the potential of individualizing treatment strategies J. Orthop. Trauma 27 2013 236 241
84. M.V. Huisman, H.R. BÃfÂ1/4ller, J.W. ten Cate, E.A. van Royen, J. Vreeken, M.J. Kersten, and et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis CHEST J. 95 1989 498 502
85. S.Z. Goldhaber, and C.G. Elliott Acute pulmonary embolism: part I epidemiology, pathophysiology, and diagnosis Circulation 108 2003 2726 2729
86. G.P. Li, L.X. Wang, and L.F. Shen The role of angelica injection on P-selectin and anti-cardiolipin antibodies in acute pulmonary embolism rats Zhongguo Ying Yong Sheng Li Xue Za Zhi 26 2010 498 501
87. J. Zagorski, M. Obraztsova, M.A. Gellar, J.A. Kline, and J.A. Watts Transcriptional changes in right ventricular tissues are enriched in the outflow tract compared with the apex during chronic pulmonary embolism in rats Physiol. Genomics 39 2009 61 71
88. J.A. Watts, M.A. Gellar, L.K. Stuart, M. Obraztsova, and J.A. Kline Proinflammatory events in right ventricular damage during pulmonary embolism: effects of treatment with ketorolac in rats J. Cardiovasc. Pharmacol. 54 2009 246 252
89. J. Zagorski, N. Sanapareddy, M.A. Gellar, J.A. Kline, and J.A. Watts Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats Physiol. Genomics 34 2008 101 111
90. M.P. Begieneman, F.R. van de Goot, I.A. van der Bilt, A. Vonk Noordegraaf, M.D. Spreeuwenberg, W.J. Paulus, and et al. Pulmonary embolism causes endomyocarditis in the human heart Heart 94 2008 450 456
91. J.C. Zhang, L. Xia, and M. Bai Changes of ICAM-1 and P-selectin in rats with pulmonary thromboembolism and the effect of safflower injection Zhongguo Zhong Xi Yi Jie He Za Zhi 26 2006 629 632
92. N.B. Adams, P.L. Lutsey, A.R. Folsom, D.H. Herrington, C.T. Sibley, N.A. Zakai, and et al. Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis J. Thromb. Haemost. 11 2013 1078 1084
93. A.L. Rodriguez, B.M. Wojcik, S.K. Wrobleski, D.D. Myers Jr., T.W. Wakefield, and J.A. Diaz Statins, inflammation and deep vein thrombosis: a systematic review J. Thromb. Thrombolysis 33 2012 371 382
94. R.J. Glynn, E. Danielson, F.A.H. Fonseca, J. Genest, A.M. Gotto Jr., J.J.P. Kastelein, and et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism N. Engl. J. Med. 360 2009 1851 1861
95. K.A. Patterson, X. Zhang, S.K. Wrobleski, A.E. Hawley, D.A. Lawrence, T.W. Wakefield, and et al. Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects Thromb. Res. 131 2013 268 276
96. M.M. Leon, E. Cojocaru, R. Cobzaru, A. Didii, and F. Mitu The role of statins in deep vein thrombosis Rev. Med. Chir. Soc. Med. Nat. Iasi 116 2012 817 822
97. D. Khemasuwan, Y.K. Chae, S. Gupta, A. Carpio, J.H. Yun, S. Neagu, and et al. Dose-related effect of statins in venous thrombosis risk reduction Am. J. Med. 124 2011 852 859
98. M. Pai, N.S. Evans, S.J. Shah, D. Green, D. Cook, and M.A. Crowther Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies Thromb. Res. 128 2011 422 430
99. D.J. Freeman, M. Robertson, E.A. Brown, A. Rumley, E.S. Tobias, M. Frolich, and et al. Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) BMC Geriatr. 11 2011 8
100. A. Perez, and J.R. Bartholomew Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed Cleve. Clin. J. Med. 77 2010 191 194
101. A.S. Ramcharan, K.J. Van Stralen, J.D. Snoep, A.K. Mantel-Teeuwisse, F.R. Rosendaal, and C.J. Doggen HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis J. Thromb. Haemost. 7 2009 514 520
102. O. Vasil'tseva, I.N. Vorozhtsova, and R.S. Karpov Thromboembolism of pulmonary artery branches from the right cardiac chambers Ter. Arkh. 85 2013 34 38
103. N.A. Zakai, P.W. Callas, A.B. Repp, and M. Cushman Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study J. Thromb. Haemost. 11 2013 634 641
104. J. Hippisley-Cox, and C. Coupland Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study BMJ 343 2011 d4656
105. M. Franchini, and P.M. Mannucci Thrombogenicity and cardiovascular effects of ambient air pollution Blood 118 2011 2405 2412
106. S. Belmouaz, E. Desport, R. Abou Ayache, A. Thierry, A. Mignot, M. Bauwens, and et al. Acute immuno-allergic interstitial nephritis caused by fluindione Clin. Nephrol. 66 2006 455 458
107. M. Wolozinsky, Y.Y. Yavin, and A.T. Cohen Pharmacological prevention of venous thromboembolism in medical patients at risk Am. J. Cardiovasc. Drugs 5 2005 409 415
108. K. Khalid Warfarin-induced necrosis of the breast: case report J. Postgrad. Med. 50 2004 268 269
109. H. Mix, S. Wagner, K. Boker, S. Gloger, K.J. Oldhafer, M. Behrend, and et al. Subacute liver failure induced by phenprocoumon treatment Digestion 60 1999 579 582
110. P.M. Kuijer, B.A. Hutten, M.H. Prins, and H.R. Buller Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism Arch. Intern. Med. 159 1999 457 460
111. G. Gonzalez-Martin, M.S. Diaz-Molinas, A.M. Martinez, and M. Ortiz Heparin-induced hyperkalemia: a prospective study Int. J. Clin. Pharmacol. Ther. Toxicol. 29 1991 446 450
112. O. Heymans, V. Lemaire, X. Nelissen, N. Verhelle, D. Jacquemin, and E. Jacob Deep vein thrombosis in a burn patient Rev. Med. Liege 57 2002 587 590
113. M.L. Bernstein, D. Esseltine, E.M. Azouz, and P. Forbes Deep venous thrombosis complicating myelomeningocele: report of three cases Pediatrics 84 1989 856 859
114. M.M. Eibl Intravenous immunoglobulins in neurological disorders: safety issues Neurol. Sci. 24 Suppl. 4 2003 S222 S226
115. G.G. Emerson, C.N. Herndon, and A.G. Sreih Thrombotic complications after intravenous immunoglobulin therapy in two patients Pharmacotherapy 22 2002 1638 1641
116. L.F. Casserly, and L.M. Dember Thrombosis in end-stage renal disease Semin. Dial. 16 2003 245 256
117. M. Schmidt, C.F. Christiansen, E. Horvath-Puho, R.J. Glynn, K.J. Rothman, and H.T. Sorensen Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism J. Thromb. Haemost. 9 2011 1326 1333
118. S. Biere-Rafi, M. Di Nisio, V. Gerdes, E. Porreca, P. Souverein, A. Boer, and et al. Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism Pharmacoepidemiol. Drug Saf. 20 2011 635 642
119. A. Bergendal, J. Adami, S. Bahmanyar, K. Hedenmalm, G. Larfars, I. Persson, and et al. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women Pharmacoepidemiol. Drug Saf. 22 2013 658 666
120. S. Mantarro, M. Tuccori, G. Pasqualetti, S. Tognini, S. Montagnani, F. Monzani, and et al. Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient BMC Geriatr. 12 2012 69
121. S.A. Johannesdottir, E. Horváth-Puhó, O.M. Dekkers, S.C. Cannegieter, J.O.L. Jørgensen, V. Ehrenstein, and et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study JAMA 173 2013 743 752
122. D.L. Davenport, H.D. Vargas, M.W. Kasten, and E.S. Xenos Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection Clin. Appl. Thromb. Hemost. 18 2012 569 575
123. M.A. Kerachian, D. Cournoyer, E.J. Harvey, T.Y. Chow, P.-E. Neagoe, M.G. Sirois, and et al. Effect of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion J. Steroid Biochem. Mol. Biol. 116 2009 127 133
124. R.T. Burkman, J.A. Collins, L.P. Shulman, and J.K. Williams Current perspectives on oral contraceptive use Am. J. Obstet. Gynecol. 185 2001 S4 S12
125. S. Cauci, M. Di Santolo, J.F. Culhane, G. Stel, F. Gonano, and S. Guaschino Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women Obstet. Gynecol. 111 2008 857 864
126. B. Allenet, S. Schmidlin, C. Genty, and J.L. Bosson Antipsychotic drugs and risk of pulmonary embolism Pharmacoepidemiol. Drug Saf. 21 2012 42 48
127. T. Pollmächer, M. Haack, A. Schuld, T. Kraus, and D. Hinze-Selch Effects of antipsychotic drugs on cytokine networks J. Psychiatr. Res. 34 2000 369 382